About Kivo Health
Kivo Health is a digital therapeutics company that delivers AI-powered virtual pulmonary rehabilitation and care programs specifically designed for people managing chronic obstructive pulmonary disease (COPD). The company's mission is to empower one billion people with chronic lung disease to breathe easier and live better. Kivo's evidence-based program is delivered entirely from patients' homes, eliminating access barriers associated with traditional in-person pulmonary rehabilitation. The program includes a comprehensive 9-week structured intervention featuring one-on-one assessments with licensed respiratory therapists, personalized small group video sessions twice weekly, targeted aerobic and anaerobic exercises, breathing techniques, medication management education, and ongoing maintenance support. Patients receive a complete kit with tablet, oxygen monitor, and exercise equipment, with cellular connectivity provided for those without WiFi. The program demonstrates strong clinical outcomes with 24% improvement in symptoms, 34% improvement in physical activity, 25% improvement in mood, and an industry-leading 83% completion rate. For healthcare partners, Kivo delivers a 3.1x return on investment, primarily through reduced inpatient and skilled nursing facility costs, with projected savings of $8,245 per member per year and nearly $10 million in annual savings per 100,000 Medicare Advantage members. The company is backed by Y Combinator and serves individuals, physicians, health systems, population health organizations, and health plans including Medicare, Medicaid, United Healthcare, Humana, Blue Cross, Aetna, Priority Health, and Clover Health.
Mission & Story
Mission
Empower one billion people with chronic lung disease to breathe easier and live better
Founding Story
Kivo Health was founded by Victor Sadauskas, MD (Co-Founder & CEO) and Vaughn Koch (Co-Founder & CTO). The company launched in February 2023 backed by Y Combinator to address the significant access barriers in traditional pulmonary rehabilitation for COPD patients.
Clinical Focus
Medical conditions and clinical areas addressed by Kivo Health.
Who It Serves
Milestones & Awards
Recent Milestones
April 2026: Partnership with Optum Arcadia for AI-powered virtual lung rehab in California. December 2025: Partnership with Priority Health. July 2025: Collaboration with Stanford Health Care. June 2025: Stanford Health Care collaboration for value-based care. May 2025: Published positive results in peer-reviewed study. February 2023: Company launch backed by Y Combinator.
Awards & Recognition
Backed by Y Combinator (2023 cohort)
Key Partnerships
Social & Media
Latest Updates
Optum Arcadia and Kivo Health Launch AI-Powered Virtual Lung Rehab and Care for Patients in California
3mo ago
Priority Health Partners with Kivo Health
7mo ago
Stanford Health Care Collaborates with Kivo Health for Virtual COPD Care
1y ago
Stanford Health Care and Kivo Health Collaborate to Advance Value Based Care for COPD through Virtual Pulmonary Rehabilitation
1y ago
Kivo Health Announces Positive Results in Peer Reviewed Study
1y ago
Company Details
- Founded
- 2023
- Employees
- 1-10
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Similar Companies in this Market
View all 46 →
Abbott Diabetes Care
Abbott Diabetes Care develops FreeStyle Libre, a world-leading continuous glucose monitoring (CGM) portfolio for diabetes management with advanced analytics and innovation.
Amalgam Rx
Amalgam Rx develops AI-powered digital therapeutics and Software as a Medical Device (SaMD) solutions for chronic disease management. The company partners with life sciences companies, health plans, and providers to deliver regulated digital health applications and EHR-integrated clinical decision support tools.
Arkray
ARKRAY USA manufactures and distributes blood glucose monitoring systems, clinical diagnostic equipment, and oral wellness products. The company serves consumers with diabetes, healthcare professionals, and clinical laboratories with accurate, affordable diagnostic solutions.
BeatO
BeatO is a digital health platform specializing in diabetes management and weight loss solutions. The company offers smart glucose monitoring devices, GLP-1 weight loss programs, and a comprehensive diabetes care program combining connected devices, doctor consultations, and health coaching for over 2 million patients across India.
Brook Health
AI-powered remote patient monitoring and chronic disease management platform for conditions like diabetes, hypertension, and heart disease.
Cadence
Cadence delivers AI-powered remote patient care programs for chronic disease management. The company partners with health systems, payers, and medical groups to provide 24/7 monitoring, medication management, and clinical support for patients with hypertension, heart failure, diabetes, and other chronic conditions.
Cala Health
Cala Health develops the Cala kIQ System, an FDA-cleared wearable device that delivers non-invasive neuromodulation therapy for action hand tremor. The device uses transcutaneous afferent patterned stimulation (TAPS) to provide on-demand tremor relief for people with essential tremor and Parkinson's disease.
Calibrate
Calibrate is a metabolic health company that combines clinician-prescribed GLP-1 medications with 1:1 video coaching and science-backed curriculum to help members achieve sustainable weight loss. Members lose an average of 19% of their body weight achieved over three years.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.